Clinilabs Revenue and Competitors

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • Clinilabs's estimated annual revenue is currently $24.7M per year.(i)
  • Clinilabs's estimated revenue per employee is $112,200

Employee Data

  • Clinilabs has 220 Employees.(i)
  • Clinilabs grew their employee count by 6% last year.

Clinilabs's People

NameTitleEmail/Phone
1
VP Clinical OperationsReveal Email/Phone
2
VP, Marketing and CommunicationsReveal Email/Phone
3
VP Finance Reveal Email/Phone
4
VP OperationsReveal Email/Phone
5
VP Global Clinical OperationsReveal Email/Phone
6
VP Project SolutionsReveal Email/Phone
7
VP, Strategy and Corporate DevelopmentReveal Email/Phone
8
VP, Contracts & ProposalsReveal Email/Phone
9
Director, Clinical OperationsReveal Email/Phone
10
Chief Operating OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$773.8M31208%$1.8MN/A
Add Company

What Is Clinilabs?

Clinilabs, Inc. is a privately-held, technology-based clinical trials organization that provides key drug development services to pharmaceutical and biotechnology companies involved in the development of new therapeutic drugs and medical devices. The company offers a wide range of services, including project development, project management, study execution at its dedicated site, electronic data capture and management for multicenter trials, and electronic subject recruitment for multicenter trials.

keywords:N/A

N/A

Total Funding

220

Number of Employees

$24.7M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Clinilabs News

2022-04-20 - Oregon to Become the First State to Legally Roll Out Psilocybin

Clinilabs has deep expertise in central nervous system drug development. CYB003 will be the first psilocybin analog to be evaluated in Phase 1/...

2022-04-17 - Cybin's Major Depressive Disorder Treatment Trials Continue With Clinilabs Drug Development Corp - Benzin

Clinilabs is to carry out Cybin's Phase 1/2a clinical trial of CYB003 for treating Major Depressive Disorder (MDD). According to the company,...

2022-04-13 - Cybin Partners with Clinilabs Drug Development Corporation for Phase 1/2a Trial Evaluating CYB003 for the Treatment of Major Depressive Disorder

Cybin Partners with Clinilabs Drug Development Corporation for Phase 1/2a Trial Evaluating CYB003 for the Treatment of Major Depressive...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$31.5M22026%N/A
#2
$35.1M2200%N/A
#3
$35.1M2206%N/A
#4
$58.8M220-5%N/A
#5
$43.6M220N/AN/A